8-K: Roth CH Acquisition Co. Announces Voluntary Delisting from Nasdaq, Plans OTC Market Transition
Delisting Announcement
Roth CH Acquisition Co. will voluntarily delist from the Nasdaq Global Market and transition to the OTC market due to non-compliance with listing rules.
Summary
- Roth CH Acquisition Co. has decided to voluntarily delist its Class A Ordinary Shares, Units, and Warrants from the Nasdaq Global Market.
- The company intends to file a Form 25 with the SEC to remove its securities from Nasdaq, with the delisting expected to be effective around April 25, 2024.
- This decision follows previous notices from Nasdaq regarding non-compliance with listing rules, specifically the requirement for at least 400 shareholders and the failure to hold an annual meeting within twelve months of the fiscal year end.
- Following the delisting, the company plans to have its securities quoted on the OTC market to maintain a trading market.
- There is no guarantee that a broker will continue to make a market for the company's securities on the OTC market.
- An Extraordinary General Meeting of Shareholders was adjourned to April 29, 2024, to allow the company additional time to complete its OTC listing.
- The company may distribute remaining funds in the trust account to shareholders after subtracting taxes and dissolution expenses, and shareholders may retain 10% of their shares if they do not redeem in connection with Proposal 1.
- The company intends to process the redemption and liquidation of the trust account within 2-3 weeks of the adoption of Proposal 1.
Sentiment
Score: 3
Explanation: The document indicates a negative development with the company's delisting from Nasdaq due to non-compliance, which is generally viewed unfavorably by investors. The move to the OTC market is also a negative signal.
Positives
- The company is taking steps to ensure continued trading of its securities on the OTC market after delisting from Nasdaq.
- Shareholders may receive a distribution from the trust account and retain 10% of their shares if they do not redeem in connection with Proposal 1.
- The company is providing a clear timeline for the delisting and transition to the OTC market.
Negatives
- The company is delisting from Nasdaq due to non-compliance with listing rules.
- There is no guarantee that a broker will continue to make a market for the company's securities on the OTC market.
- The company failed to meet Nasdaq's minimum shareholder requirement of 400 and did not hold an annual meeting within the required timeframe.
Risks
- There is a risk that trading of the company's securities may not continue on the OTC market.
- The company's share price may be negatively impacted by the delisting from Nasdaq.
- The company faces uncertainty regarding the acceptance of its securities on the OTC market.
- The company is subject to risks associated with general economic and market conditions, competitive factors, and customer acceptance of new product offerings.
Future Outlook
The company expects to have its securities quoted on the OTC market following the delisting from Nasdaq, but there is no guarantee that a broker will continue to make a market in the company's securities.
Management Comments
- The company has notified Nasdaq of its decision to voluntarily delist its securities.
- The company intends to file a Form 25 with the SEC to remove its securities from listing on the Nasdaq Global Market.
- The company expects to have its securities quoted on the OTC market following the delisting.
Industry Context
The delisting of Roth CH Acquisition Co. highlights the challenges faced by some SPACs in maintaining listing requirements, particularly regarding shareholder numbers and corporate governance. This is not an uncommon issue in the current market environment.
Comparison to Industry Standards
- Many SPACs have struggled to maintain Nasdaq listing requirements, particularly the minimum shareholder count.
- The move to the OTC market is a common path for companies that fail to meet Nasdaq's listing standards.
- The lack of an annual meeting within the required timeframe is a significant governance issue that is not typical for well-run public companies.
- The redemption process and potential distribution of trust funds is a standard procedure for SPACs that do not complete a business combination.
Stakeholder Impact
- Shareholders will be impacted by the delisting from Nasdaq and the transition to the OTC market.
- Shareholders may receive a distribution from the trust account and retain 10% of their shares if they do not redeem in connection with Proposal 1.
- The company's employees may be affected by the uncertainty surrounding the company's future.
Next Steps
- The company will file a Form 25 with the SEC to remove its securities from Nasdaq.
- The company will transition its securities to the OTC market.
- The Extraordinary General Meeting will reconvene on April 29, 2024.
- The company will process the redemption and liquidation of the trust account within 2-3 weeks of the adoption of Proposal 1.
Key Dates
| Date | Description |
|---|---|
| 2022-12-31 | Company's fiscal year end for which an annual meeting was not held within 12 months. |
| 2023-10-16 | Company received notice from Nasdaq regarding non-compliance with Listing Rule 5450(a)(2). |
| 2024-01-29 | Company received notice from Nasdaq regarding non-compliance with Listing Rule 5620(a). |
| 2024-04-10 | Extraordinary General Meeting of Shareholders was adjourned. |
| 2024-04-15 | Company announced its decision to voluntarily delist from Nasdaq. |
| 2024-04-17 | Date of the 8-K filing and reconvening of the Extraordinary General Meeting. |
| 2024-04-25 | Expected date for the delisting from Nasdaq to become effective. |
| 2024-04-29 | Reconvened date for the Extraordinary General Meeting of Shareholders. |
Keywords
delisting, Nasdaq, OTC market, shareholders, listing rules, redemption, trust account, securities, Form 25, voluntary delisting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.